Evidence map›Paper›PMID 32956745›Full record

ArticleInternational journal of radiation oncology, biology, physics2021

US Radiation Oncologists (Re)Defined: An American Society for Radiation Oncology Scope of Practice Study.

Claire Y Fung, Neha Vapiwala, Malcolm D Mattes, Pranshu Mohindra, Chirag Shah, Raphael Yechieli, Minh-Tam Truong, Tim Sanders, Anna Arnone, Trevor J Royce and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. A Primer on Radiopharmaceutical Therapy.International journal of radiation oncology, biology, physics · 2023
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 10 institutions in 1 country.

Claire Y FungBeth Israel Deaconess Medical Center, Boston, Massachusetts.
Neha VapiwalaUniversity of Pennsylvania, Philadelphia, Pennsylvania.
Malcolm D MattesRutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
Pranshu MohindraUniversity of Maryland, Baltimore, Maryland.
Chirag ShahCleveland Clinic, Cleveland, Ohio.
Raphael YechieliUniversity of Miami, Miami, Florida.
Minh-Tam TruongBoston University School of Medicine, Boston, Massachusetts.
Tim SandersAmerican Society for Radiation Oncology, Arlington, Virginia.
Anna ArnoneAmerican Society for Radiation Oncology, Arlington, Virginia.
Trevor J RoyceUniversity of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina.
Ronald D EnnisRutgers Cancer Institute of New Jersey, New Brunswick, New Jersey. Electronic address: re230@cinj.rutgers.edu.
American Society for Radiation Oncology · USBeth Israel Deaconess Medical Center · USBoston University · USCleveland Clinic · USRutgers Cancer Institute of New JerseyRutgers, The State University of New Jersey · USUniversity of Maryland, Baltimore · USUniversity of Miami · USUniversity of North Carolina at Chapel Hill · USUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo assess US radiation oncologists' views on practice scope and the ideal role of the radiation oncologist (RO), the American Society for Radiation Oncology (ASTRO) conducted a scope of practice survey. METHODS AND MATERIALS: In spring 2019, ASTRO distributed an online survey to 3822 US RO members. The survey generated 984 complete responses (26% response rate) for analysis. Face validity testing confirmed respondents were representative of ASTRO's RO membership.

resultsNearly all respondents agreed that "ROs should be leaders in oncologic care." Respondents indicated the ideal approach to patient care was to provide "an independent opinion on radiation therapy and other treatment options" (82.5%) or "an independent opinion on radiation therapy but not outside of it" (16.1%), with only 1.4% favoring provision of "radiation therapy at the request of the referring physician" as the ideal approach. Actual practice fully matched the ideal approach in 18.2% of respondents. For the remaining majority, actual practice did not always match the ideal and comprised a mix of approaches that included providing radiation at the referring physician's request 24.0% of the time on average. Reasons for the mismatch included fear of alienating referring physicians and concern for offering an unwelcome opinion. One-fifth of respondents expressed a desire to expand the scope of service though interspecialty politics and insufficient training were potential barriers. Respondents interested in expanding scope of practice were on average earlier in their career (average years in practice 13.3) than those who were not interested (average years in practice 17.2, P < .001). Radiopharmaceuticals administration, medical marijuana and anticancer medications prescribing, and RO inpatient service represented areas of interest for expansion but also knowledge gaps.

conclusionsThese results provide insight regarding US ROs' scope of practice and attitudes on the ideal role of the RO. For most ROs, to provide an independent opinion on treatment options represented the ideal approach to care, but barriers such as concern of alienating referring physicians prevented many from fully adhering to their ideal in practice. Actual practice commonly comprised a mixed approach, including the least favored scenario of delivering radiation at the referring physician's request one-quarter of the time, highlighting the influence of interspecialty politics on practice behavior. Advocacy for open communication and meaningful interdisciplinary collaboration presents an actionable solution toward a more balanced relationship with other specialties as ROs strive to better fulfill the vision of being leaders in oncologic care and being our best for our patients. The study also identified interest in expanding into nontraditional domains that offer opportunities to address unmet needs in the cancer patient's journey and elevate radiation oncology within the increasingly value-based US health care system.

Indexed as

Surveys and QuestionnairesHumansRadiation OncologistsSocieties, MedicalTime FactorsUnited States

Identifiers

PMID32956745
PMCPMC7500393
OpenAlexW3087586788

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.